Abiopharma

SEI Launches ANGU ETF, Bringing Factor Research to Traditional Index Exposure

Bronstein, Gewirtz & Grossman LLC Urges Avis Budget Group, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

Georgia Power Generation employees keep reliable energy flowing throughout the hottest days of summer

MiNK Therapeutics Presents Early Observations from Ongoing Phase 2 Trial at the 2026 Military Health System Research Symposium

Mortgage Rates Average 6.69%

Northwest Biotherapeutics Announces MOU for Collaboration With the Saudi Pharmaceutical Industries and Medical Appliance Company

Chemed Corporation Declares Quarterly Dividend of 70 Cents

Theriva™ Biologics anuncia que se ha administrado la primera dosis a un paciente en el ensayo clínico VIRAGE2 de Fase IIa, destinado a evaluar una administración más frecuente de VCN-01 (zabilugene almadenorepvec) en pacientes en tratamiento de primera línea con adenocarcinoma ductal pancreático metastásico

Dogfish Head to Host Dog & Owner Lookalike Contest this National Dog Day

Elong Power Holding Limited Announces the Change of Effective Date of its 1 for 45 Share Consolidations

KLÉPIERRE RELEASES ITS FIRST-HALF 2026 FINANCIAL REPORT

MISE À DISPOSITION DU RAPPORT FINANCIER SEMESTRIEL 2026

Donaldson to Webcast Fourth Quarter Fiscal 2026 Earnings Conference Call

Déclaration mensuelle relative au nombre total de droits de vote et dactions composant le capital social au 31 juillet 2026

Monthly disclosure on share capital and voting rights on July 31, 2026